Zenarestat

Zenarestat (FK-366; FR-74366) is an aldose reductase inhibitor.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Zenarestat (FK-366; FR-74366) is an aldose reductase inhibitor. It was investigated as a treatment of diabetic neuropathy and cataract, but its development was terminated.

References

M. Hashimoto et al., EP 218999; eidem, US 4734419 (1987, 1988 both to Fujisawa) Inhibition kinetics and effect on sorbitol accumulation: S. Ao et al., Metabolism 40, 77 (1991) Pharmacokinetics and metabolism in diabetic rats: Y. Tanaka et al., Drug Metab. Dispos. 21, 677 (1993) M. Kanamaru et al., J. Clin.

Pharmacol. 33, 1122 (1993).

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330642061 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.